Worldwide trends in lung cancer pathology

Abstract:  Molecular profiling studies serve to remind us that lung cancer is a complex disease, with different phenotypes that are characterized by variation in morphology as well as molecular composition. Over recent decades, there appear to be worldwide shifts in the relative frequencies of various phenotypic patterns of lung cancer, which are even more striking than changes in the overall incidence of lung cancer. This review summarizes major worldwide trends in lung cancer pathology, which can be explained in part, but not entirely, by changes in cigarette design. Characterizing these trends will be important for recognizing contributions of carcinogens other than tobacco smoke to the worldwide problem of lung cancer.

[1]  F. Schmidt.  Meta-Analysis , 2008 .

[2]  R. Wilson,et al.  Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Minna,et al.  Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. , 2006, Journal of the National Cancer Institute.

[4]  C. Clavel,et al.  Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases , 2005, Modern Pathology.

[5]  F. Bray,et al.  International lung cancer trends by histologic type: Male:Female differences diminishing and adenocarcinoma rates rising , 2005, International journal of cancer.

[6]  W. Lam.  Lung cancer in Asian women—the environment and genes * , 2005, Respirology.

[7]  Laurie Kazan-Allen,et al.  Asbestos and mesothelioma: worldwide trends. , 2005, Lung cancer.

[8]  P. Hainaut,et al.  TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. , 2005, Cancer research.

[9]  A. Sandler,et al.  Redefining bronchioloalveolar carcinoma. , 2005, Seminars in oncology.

[10]  Young Tae Kim,et al.  Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Takayuki Kosaka,et al.  Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Meyerson,et al.  EGFR gene mutations: a call for global x global views of cancer. , 2005, Journal of the National Cancer Institute.

[13]  A. Marchetti,et al.  EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  T. Joshi,et al.  Asbestos in Developing Countries: Magnitude of Risk and Its Practical Implications , 2005, International journal of occupational medicine and environmental health.

[15]  Takayuki Kosaka,et al.  Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer , 2004, Cancer Research.

[16]  D. Christiani,et al.  Lung adenocarcinoma and human papillomavirus infection , 2004, Cancer.

[17]  R. Wilson,et al.  EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Chan-yeung,et al.  Lung cancer epidemiology and risk factors in Asia and Africa. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[19]  S. Gabriel,et al.  EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.

[20]  Patricia L. Harris,et al.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.

[21]  Giovanni Parmigiani,et al.  A Cross-Study Comparison of Gene Expression Studies for the Molecular Classification of Lung Cancer , 2004, Clinical Cancer Research.

[22]  K. Shah,et al.  Chapter 9: Role of mucosal human papillomavirus in nongenital cancers. , 2003, Journal of the National Cancer Institute. Monographs.

[23]  J. Cerhan,et al.  Adenocarcinoma of the lung is strongly associated with cigarette smoking: further evidence from a prospective study of women. , 2002, American journal of epidemiology.

[24]  M. Kris,et al.  Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. , 2002, The Annals of thoracic surgery.

[25]  David E. Misek,et al.  Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.

[26]  David Sidransky,et al.  Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. , 2002, Cancer research.

[27]  W. Travis.  Pathology of lung cancer. , 2002, Clinics in chest medicine.

[28]  E. Lander,et al.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Botstein,et al.  Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Olivier,et al.  Lung tumor KRAS and TP53 mutations in nonsmokers reflect exposure to PAH-rich coal combustion emissions. , 2001, Cancer Research.

[31]  G. Sheu,et al.  The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. , 2001, Cancer research.

[32]  S. Khuder,et al.  Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. , 2001, Lung cancer.

[33]  E. Lander,et al.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Sidransky,et al.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.

[35]  Takashi Takahashi,et al.  Risk Factors for Lung Cancer among Northern Thai Women: Epidemiological, Nutritional, Serological, and Bacteriological Surveys of Residents in High‐ and Low‐incidence Areas , 1999, Japanese journal of cancer research : Gann.

[36]  K. Shroyer,et al.  Detection of human papillomavirus in squamous cell carcinomas of the lung by polymerase chain reaction. , 1998, American journal of respiratory cell and molecular biology.

[37]  Chih-Yi Chen,et al.  Analysis of K-ras gene mutations in lung carcinomas: correlation with gender, histological subtypes, and clinical outcome , 1998, Journal of Cancer Research and Clinical Oncology.

[38]  M. Djordjevic,et al.  The changing cigarette. , 1997, Preventive medicine.

[39]  S. Hecht,et al.  The biological significance of tobacco-specific N-nitrosamines: smoking and adenocarcinoma of the lung. , 1996, Critical reviews in toxicology.

[40]  E. Wynder,et al.  The changing epidemiology of smoking and lung cancer histology. , 1995, Environmental health perspectives.

[41]  C. Harris,et al.  Mutagens from heated Chinese and U.S. cooking oils. , 1995, Journal of the National Cancer Institute.

[42]  M. Lung,et al.  Incidence of ras oncogene activation in lung carcinomas in Hong Kong , 1992, Cancer.

[43]  A. Seaton,et al.  Asbestos: scientific developments and implications for public policy. , 1990, Science.

[44]  J. Chuang,et al.  Lung cancer and indoor air pollution in Xuan Wei, China. , 1987, Science.

[45]  A. Churg.  Lung cancer cell type and asbestos exposure. , 1985, JAMA.

[46]  J. Lubin,et al.  Assessment of lung cancer risk factors by histologic category. , 1984, Journal of the National Cancer Institute.

[47]  J H Holbrook,et al.  The changing cigarette. , 1981, The Western journal of medicine.

[48]  I J Selikoff,et al.  ASBESTOS EXPOSURE, CIGARETTE SMOKING AND DEATH RATES * , 1979, Annals of the New York Academy of Sciences.